{"page":{"totalFilteredElements":347},"studies":[{"active":true,"description":"Prostate Cancer Outcomes &#8211; Compare &amp; Reduce Variation in&#160; DKG - zertifizierten&#160; Prostatakrebszentren<br /><div><br /></div><div>DRKS00010774<br /></div>","eudractNumber":null,"id":4571,"indications":[{"id":"pro","name":"Prostatakrebs"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2018-12-02T13:28:48+01:00","shortTitle":"PCO-D Studie","therapeutical":false,"therapyLines":[]},{"active":true,"description":"Prostate Cancer Outcomes &#8211; Compare &amp; Reduce Variation in&#160; DKG - zertifizierten&#160; Prostatakrebszentren<br /><div><br /></div><div>DRKS00010774</div>","eudractNumber":null,"id":4239,"indications":[{"id":"pro","name":"Prostatakrebs"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2017-07-01T11:40:15+02:00","shortTitle":"PCO-D Studie","therapeutical":false,"therapyLines":[]},{"active":true,"description":"Pr&#228;vention von fr&#252;hen Darmkrebserkrankungen - PEARL","eudractNumber":null,"id":11520,"indications":[{"id":"giu","name":"Bösartige Erkrankungen des unteren Verdauungstraktes (Darm, Leber/Gallenblase, Pankreas)"},{"id":"giu1","name":"Karzinome des Dünn- und Dickdarms (Kolon, Rektum, Anus)"}],"mutations":[],"nctNumber":"NCT05541601","phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2022-10-10T09:48:39+02:00","shortTitle":"PEARL","therapeutical":false,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"<div>PERSUASION</div><div>New Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION) a permanent platform including all kind of biliary tract cancers (BTC)</div>","eudractNumber":null,"id":9177,"indications":[{"id":"giu","name":"Bösartige Erkrankungen des unteren Verdauungstraktes (Darm, Leber/Gallenblase, Pankreas)"},{"id":"giu2","name":"Leber (Hepatozelluläres Karzinom, HCC) / Gallenblase-/wege (Cholangiozelluläres Karzinom, CCC)"}],"mutations":[],"nctNumber":"NCT04896931","phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2023-01-30T21:22:13+01:00","shortTitle":"PERSUASION","therapeutical":false,"therapyLines":[]},{"active":true,"description":"A multi-center randomized, double blinded phase IIb trial evaluating oral pooled fecal microbiotherapy MaaT033 to prevent allogeneic hematopoietic cell transplantation complications. (PHOEBUS)","eudractNumber":"2022-501831-18","id":11222,"indications":[{"id":"nen","name":"Bösartige Tumoren der Nebenniere"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_16","name":"IIB"},"recruitmentStart":"2025-11-27T09:04:11+01:00","shortTitle":"PHOEBUS - MPOH08","therapeutical":true,"therapyLines":[{"id":"tl_5","name":"N/A"}]},{"active":true,"description":"PRESS -PAR: Early detection and PREvention of Symptomatic\npostSurgical hypoPARathyroidism\nafter thyroid surgery","eudractNumber":null,"id":9865,"indications":[{"id":"nen","name":"Bösartige Tumoren der Nebenniere"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2024-07-15T15:27:25+02:00","shortTitle":"PRESSPAR","therapeutical":false,"therapyLines":[]},{"active":true,"description":"A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma","eudractNumber":"2024-513317-12-00","id":9932,"indications":[{"id":"giu","name":"Bösartige Erkrankungen des unteren Verdauungstraktes (Darm, Leber/Gallenblase, Pankreas)"},{"id":"giu3","name":"Bauchspeicheldrüsenkrebs (Pankreaskarzinom)"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_9","name":"Phase III"},"recruitmentStart":"2025-04-30T09:54:54+02:00","shortTitle":"PRISM-1","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"Evaluation der DIGA consilium care bei Patientinnen mit Her 2 positiven Brustkrebs w&#228;hrend einer Chemotherapie in Kombination mit einer Her 2 zielgerichteten Antik&#246;rper Therapie","eudractNumber":null,"id":8562,"indications":[{"id":"bru","name":"Brustkrebs (Mammakarzinom)"}],"mutations":[],"nctNumber":"NCT05425550","phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2023-06-01T09:40:37+02:00","shortTitle":"PRO2","therapeutical":true,"therapyLines":[{"id":"tl_5","name":"N/A"}]},{"active":true,"description":"<div>PROstate CAncer Real World Evidence Registry: Registerstudie zur Erfassung des Therapie- und Krankheitsverlaufs bei Patienten mit rezidiviertem und metastasiertem Prostatakrebs</div><div><br /></div><div>DRKS00033411</div>","eudractNumber":null,"id":10394,"indications":[{"id":"pro","name":"Prostatakrebs"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2024-11-07T10:02:33+01:00","shortTitle":"PROCARE","therapeutical":false,"therapyLines":[{"id":"tl_5","name":"N/A"}]},{"active":true,"description":"Real world experience of patients with metastatic castration resistant prostate Cancer treated with Olaparib+Abiraterone","eudractNumber":null,"id":9252,"indications":[{"id":"pro","name":"Prostatakrebs"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2024-02-01T13:58:55+01:00","shortTitle":"PROCEED","therapeutical":false,"therapyLines":[]}]}